Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Return on Capital Employed (2016 - 2026)

Rockwell Medical filings provide 15 years of Return on Capital Employed readings, the most recent being 9.83% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 1121.0% to 9.83% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.83%, a 1121.0% decrease, with the full-year FY2025 number at 9.65%, down 1111.0% from a year prior.
  • Return on Capital Employed hit 9.83% in Q4 2025 for Rockwell Medical, up from 10.58% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 1.42% in Q3 2024 to a low of 127.21% in Q1 2022.
  • Median Return on Capital Employed over the past 5 years was 37.25% (2023), compared with a mean of 40.96%.
  • Biggest five-year swings in Return on Capital Employed: crashed -8304bps in 2022 and later surged 8654bps in 2023.
  • Rockwell Medical's Return on Capital Employed stood at 92.85% in 2021, then skyrocketed by 45bps to 51.29% in 2022, then soared by 64bps to 18.66% in 2023, then skyrocketed by 107bps to 1.38% in 2024, then crashed by -812bps to 9.83% in 2025.
  • The last three reported values for Return on Capital Employed were 9.83% (Q4 2025), 10.58% (Q3 2025), and 3.05% (Q2 2025) per Business Quant data.